Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Acta Crystallographica. Section E, Crystallographic Communications|November 21, 2017
The crystal structures of two isomers of 5-(phenyl-iso-thia-zol-yl)-1,3,4-oxa-thia-zol-2-oneShuguang Zhu, Melbourne J Schriver, Arthur D Hendsbee, et al.
Acta Crystallographica. Section C, Structural Chemistry|March 15, 2023
Synthesis and crystal structures of halogenated oxathiazolones and an unexpected propanamideTanner George, Samantha W McWilliams, Jason D Masuda, et al.
Acta Crystallographica. Section E, Crystallographic Communications|September 22, 2017
Crystal structure determination as part of an ongoing undergraduate organic laboratory project: 5-[(E)-styr-yl]-1,3,4-oxa-thia-zol-2-oneTrevor R Nason, Melbourne J Schriver, Arthur D Hendsbee, et al.
The Journal of Experimental Medicine|October 30, 2009
BIOLOGICAL AND PHYSICAL PROPERTIES OF THE HEMOTOXIN OF STREPTOCOCCIP D Meader, G H Robinson
Cancer Research|April 12, 2013
Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic miceBarbara Sennino, Toshina Ishiguro-Oonuma, Brian J Schriver, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|April 28, 2001
Mandibular distraction force: laboratory data and clinical correlationR C Robinson, P J O'Neal, G H Robinson
Frontiers in Bioengineering and Biotechnology|September 29, 2023
Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatmentKai Wang, Brian J Schriver, Roozbeh Aschar-Sobbi, et al.
Pageof 3